科技报告详细信息
Development of Solid State NMR Methods for the Structural Characterisation of Membrane Proteins: Applications to Understand Multiple Sclerosis.
Cosman, M. ; Tran, A. T. ; Ulloa, J. ; Maxwell, R. S.
Technical Information Center Oak Ridge Tennessee
关键词: Multiple sclerosis;    Nervous system disorders;    Central nervous system;    Nuclear magnetic resonance;    Autoimmune disease;   
RP-ID  :  DE200415007469
学科分类:工程和技术(综合)
美国|英语
来源: National Technical Reports Library
PDF
【 摘 要 】
Multiple sclerosis (MS) is a relapsing-remitting disorder of the central nervous system that results in the loss of the myelin sheaths insulating nerve fibers (axons). Strong evidence suggests that MS is an autoimmune disease mediated by T-cell and antibody responses against myelin antigens. Myelin oligodendrocyte glycoprotein (MOG) is a 26 kD to 28 kD an integral membrane protein of the central nervous system implicated as a target for autoaggressive antibodies in MS. To date, the conformation of MOG in association with the myelin membrane is unknown and the exact nature of the interactions between this protein and dlsease-inducing immune responses have not been determined. Since membrane associated proteins are typically characterized by decreased correlation times, solution state NMR methodologies are often impracticable. Membrane proteins are also often difficult to crystallize for X-ray diffraction studies, Consequently, there is an urgent need to develop new structure characterization tools for this important class of biomolecules. The research described here overviews the initial stages of our effort to develop an integrated, NMR based approach to structural studies of MOG over the many structural domains it is postulated to posess. The structural knowledge gained about this important MS antigen in its native environment will contribute significantly to our understanding of its function in vivo. This project will also aid in the development of therapeutics to inhibit the antigedantibody interaction and thus prevent demyelination in MS patients.
【 预 览 】
附件列表
Files Size Format View
DE200415007469.pdf 1381KB PDF download
  文献评价指标  
  下载次数:12次 浏览次数:48次